--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
Salesforce
CRM
Apple
AAPL
Microsoft
MSFT
Meta Platforms
META
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
PALI Palisade Bio
- 2.2990
- +0.8990+64.21%
Trading Dec 12 15:54 ET
3.28MMarket Cap-0.17P/E (TTM)
3.3000High1.9100Low67.18MVolume2.8500Open1.4000Pre Close174.65MTurnover5258.96%Turnover RatioLossP/E (Static)1.43MShares22.350052wk High0.50P/B2.94MFloat Cap1.380052wk Low--Dividend TTM1.28MShs Float594000.0000Historical High--Div YieldTTM99.29%Amplitude1.3800Historical Low2.5990Avg Price1Lot Size
Palisade Bio Key Stats
Palisade Bio Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Palisade Bio Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data